Mickens Lauren D, Nghiem Duyen M, Wygant Dustin B, Umlauf Robert L, Marek Ryan J
University of Houston-Clear Lake, Houston, TX, USA.
Eastern Kentucky University, Richmond, KY, USA.
J Clin Psychol Med Settings. 2021 Dec;28(4):789-797. doi: 10.1007/s10880-021-09766-4. Epub 2021 Feb 22.
Chronic pain has become a significant medical issue. The Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) is a broadband psychological test that has been validated for use across various medical settings and can aid in the assessment and treatment planning of chronic pain. In the current investigation, it was hypothesized that the somatic complaints scales of the MMPI-2-RF would demonstrate good convergent validity from a structured psychodiagnostic interview and other measures of pain and somatization, and lack gender bias. Patients (n = 200) who produced valid MMPI-2-RFs in an outpatient chronic pain clinic were included in the study. Patients were also administered the Modified Somatic Perception Questionnaire (MSPQ), Pain Disability Index (PDI), and the Structured Clinical Interview for DSM-IV-TR (SCID). Zero-order and partial correlations (controlling for gender) were calculated between MMPI-2-RF scale scores and other criteria. Stepdown hierarchical regression analyses were used to detect bias. By and large, higher scale scores on the somatic/cognitive scales of the MMPI-2-RF were modestly or substantially correlated with MSPQ scores, PDI scores, and SCID Somatization symptom count, even after controlling for gender. Regression analyses suggested that the MMPI-2-RF scale scores were not biased as a function of gender. These findings support the validity of specific MMPI-2-RF scales to help identify somatization and psychosocial functioning among patients with chronic pain. Identification of somatization early within the course of treatment of chronic pain may help focus treatment targets, including referrals for psychological interventions such as cognitive behavior therapy for chronic pain.
慢性疼痛已成为一个重大的医学问题。明尼苏达多相人格问卷第二版修订版(MMPI - 2 - RF)是一种广泛应用的心理测试,已在各种医疗环境中得到验证,可辅助慢性疼痛的评估和治疗规划。在当前的调查中,研究假设MMPI - 2 - RF的躯体主诉量表在结构化心理诊断访谈以及其他疼痛和躯体化测量中具有良好的收敛效度,且不存在性别偏见。本研究纳入了在门诊慢性疼痛诊所提供有效MMPI - 2 - RF测试结果的200名患者。患者还接受了改良躯体感知问卷(MSPQ)、疼痛残疾指数(PDI)以及《精神疾病诊断与统计手册第四版修订版》结构化临床访谈(SCID)。计算了MMPI - 2 - RF量表得分与其他标准之间的零阶和偏相关(控制性别因素)。采用逐步分层回归分析来检测偏差。总体而言,即使在控制性别因素后,MMPI - 2 - RF躯体/认知量表上较高的量表得分与MSPQ得分、PDI得分以及SCID躯体化症状计数之间存在适度或显著的相关性。回归分析表明,MMPI - 2 - RF量表得分不存在因性别而产生的偏差。这些发现支持了特定MMPI - 2 - RF量表在帮助识别慢性疼痛患者的躯体化和心理社会功能方面的效度。在慢性疼痛治疗过程中早期识别躯体化现象可能有助于明确治疗目标,包括转介接受心理干预,如慢性疼痛的认知行为疗法。